Analysis of Crosslinked and Conventional Polyethylene Explants

January 23, 2017 updated by: Anderson Orthopaedic Research Institute

Collaborative Analysis of UHMWPE Explants: Conventional UHMWPE With No Radiation and Marathon

This retrospective study will investigate the changes that occur in ultrahigh molecular weight polyethylene (UHMWPE) implants that have been retrieved from joint replacement patients. Analysis techniques will include Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimeter (DSC) and crosslink density measurements. Crosslink density measurements will be evaluated as a function of distance away from the articular surface and the rim of the implant. Gel and hydroperoxide contents will also be evaluated. The objective is to characterize the in vivo and ex vivo changes that occur with cross-linked and conventional polyethylene bearings sterilized by methods that do not involve radiation. The investigators hypothesize that polyethylene absorbs lipids in vivo but experiences negligible oxidation or reductions in polymer crosslinking until it is explanted and stored at room temperature with access to ambient air.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

For many years, gamma-irradiation in air was a common method for the terminal sterilization of ultrahigh molecular weight polyethylene (UHMWPE) materials used for joint replacement. A serendipitous byproduct of sterilization with gamma-irradiation was polymer crosslinking that tended to improve the wear performance of the polyethylene. During the 1990s, however, the orthopaedic community became aware that gamma-irradiation created free radicals within polyethylene, rendering the material susceptible to oxidative degradation. In view of this potentially deleterious effect, terminal sterilization methods using chemical surface treatments were developed to avoid free radical formation. To induce polyethylene crosslinking without residual free radicals, manufacturers also developed methods to crosslink the polyethylene followed by heat treatments to eliminate free radicals. These crosslinked materials were introduce during the latter part of the 1990s and clinical outcome studies among hip replacement patients have demonstrated substantially reduced wear at early follow-up intervals based on radiographic measurements. However, the long-term performance of crosslinked polyethylene is unknown and some investigators have expressed concerns related to in vivo degradation. Additionally, some crosslinked UHMWPE components have shown high levels of oxidation and chain scission after removal from patients and storage in air. Among these implants, it is unknown whether the oxidation and chain scission occurred during implantation or after the polyethylene was removed from the patient.

This study will characterize the material properties of polyethylene liners retrieved from hip replacement patients. The study population will include crosslinked and conventional UHMWPE liners that were terminally sterilized without the use of radiation. To quantify the potential effects of different storage methods, liners that were vacuum packed and frozen after retrieval and others that were stored at room temperature with access to ambient light and air following explantation will be included in the study population. Analysis techniques will include Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimeter (DSC) and crosslink density measurements. Crosslink density measurements will be evaluated as a function of distance away from the articular surface and the rim of the implant. Gel and hydroperoxide contents will also be evaluated. The goal of the analysis is to better understand the changes in polyethylene material properties that occur in vivo and ex vivo.

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Orthopaedic Biomechanics and Biomaterials Laboratory at Massachusetts General Hospital
    • Virginia
      • Alexandria, Virginia, United States, 22306
        • Anderson Orthopaedic Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Crosslinked and conventional polyethylene liners terminally sterilized without gamma-irradiation will be used for this study. Specimens will be selected from the implant retrieval collection maintained by the Anderson Orthopaedic Research Institute.

Description

Inclusion Criteria:

  • Retrieved total hip arthroplasty liners maintained by the Anderson Orthopaedic Research Institute
  • Crosslinked or conventional liners terminally sterilized without gamma-irradiation

Exclusion Criteria:

  • Liners terminally sterilized with gamma-irradiation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Crosslinked polyethylene liners
Polyethylene liners from joint replacements that were crosslinked and heat treated to eliminate free radicals.
Replacement of a patient's native hip with an artificial implant featuring a metal-on-polyethylene articulation
Other Names:
  • DePuy Marathon crosslinked polyethylene
  • DePuy Enduron conventional polyethylene
Conventional polyethylene liners
Polyethylene liners from joint replacements that manufactured from conventional UHMWPE and terminally sterilized by methods that did not involve gamma-irradiation.
Replacement of a patient's native hip with an artificial implant featuring a metal-on-polyethylene articulation
Other Names:
  • DePuy Marathon crosslinked polyethylene
  • DePuy Enduron conventional polyethylene

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxidation levels
Time Frame: At an average of 5 years in vivo
Polyethylene oxidation levels will be quantified as a function of depth away from the articular and rim surfaces using Fourier Transform Infrared Spectroscopy (FTIR). Pre and post-hexane and nitric oxide (NO) exposed post-hexane thin sections will be analyzed.
At an average of 5 years in vivo

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Absorbed lipids
Time Frame: At an average of 5 years in vivo
Absorbed lipids will be evaluated by determining the level of carbonyls before and after hexane extraction using Fourier Transform Infrared Spectroscopy (FTIR).
At an average of 5 years in vivo
Crosslink density
Time Frame: At an average of 5 years in vivo
Crosslink density will be evaluated using the gravimetric method on thin sections (~300μm) cut co-planar to the articular surfaces.
At an average of 5 years in vivo
Differential Scanning Calorimeter (DSC)
Time Frame: At an average of 5 years in vivo
Differential Scanning Calorimeter (DSC) will be used to determine the 1st and 2nd heats, and 1st cool crystallinity, peak melting/crystallization points.
At an average of 5 years in vivo
Hydroperoxides
Time Frame: At an average of 5 years in vivo
Hydroperoxides will be evaluated with FTIR by NO treatment after hexane extraction.
At an average of 5 years in vivo
Vinyl end-groups
Time Frame: At an average of 5 years in vivo
Vinyl end-groups will be evaluated with FTIR after hexane extraction to quantify chain scission.
At an average of 5 years in vivo
Trans vinylene (TVI) unsaturations
Time Frame: At an average of 5 years in vivo
Trans vinylene (TVI) unsaturations will be evaluated with FTIR after hexane extraction to determine radiation history and dose.
At an average of 5 years in vivo
Crystallinity
Time Frame: At an average of 5 years in vivo
Infra-red crystallinity will be evaluated with FTIR after hexane extraction.
At an average of 5 years in vivo
Gel content
Time Frame: At an average of 5 years in vivo
To quantify the extent of chain scission, gel content will be evaluated by measuring the non-extractable portion of the molecules using thin sections cut co-planar to the articular surfaces with a microtome and extracting the polyethylene chains from these sections in hot xylene.
At an average of 5 years in vivo

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Robert H Hopper, Jr., PhD, Anderson Orthopaedic Research Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (Anticipated)

December 1, 2017

Study Completion (Anticipated)

December 1, 2017

Study Registration Dates

First Submitted

November 28, 2011

First Submitted That Met QC Criteria

November 30, 2011

First Posted (Estimate)

December 2, 2011

Study Record Updates

Last Update Posted (Estimate)

January 24, 2017

Last Update Submitted That Met QC Criteria

January 23, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • AORI2011-0101
  • MGH Agreement No: A208947 (Other Grant/Funding Number: DePuy Orthopaedics, Inc.)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Clinical Trials on Total hip arthroplasty

3
Subscribe